NYSE · SERVICES-HOSPITALS · LARGE CAP
Pediatrix Medical Group, Inc. MD
18 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$1.9B
▼ 4.9% vs FY2024
EPS · FY25
$1.94
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
20.3%
Net margin · FY25
8.6%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 1.9B
Revenue, FY2025 · full 18-year series below
Revenue
Net income
9 cents of every revenue dollar became profit this year.
Per share
USD 1.94
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
20.3%
Return on equity, FY2025
ROE
Operating margin10.9%
Net margin8.6%
Return on assets7.5%
Each USD of equity produced 20 cents of profit this year.
Returned to shareholders
USD 83.5M
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacksUSD 83.5M
Share of profit50.5%
Consecutive raises—
USD 83.5M in buybacks — 50% of the year's profit went back to shareholders.
Growth
+2.0% a year
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−1.0%
+2.0%
Net income
+35.6%
−6.9%
−1.3%
EPS, diluted
+34.9%
−5.9%
Returned to shareholders
+0.2%
+123.9%
−9.0%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
0.08B
Shares outstanding, FY2025
Change, 5 years−3.1%
Change, 10 years−11.5%
The share count shrank 3% in five years — the same company, cut into fewer, larger slices.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 2.2B
total assets, end of FY2025
Total assetsUSD 2.2B
EquityUSD 865.9M
CashUSD 375.2M
Gross debtUSD 570.5M
Net debtUSD 195.3M
Current ratio1.66×
Net debt stands at 23% of equity.
History
18 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
Revenue $B
1.9
2.0
2.0
2.0
1.9
1.7
1.8
1.7
3.3
3.2
·
·
·
·
·
·
·
·
Operating income $B
0.2
−0.1
0.0
0.2
0.2
0.1
0.2
0.2
0.5
0.6
0.6
0.5
0.5
0.4
0.4
0.3
0.3
0.2
EBITDA $B
0.2
−0.0
0.0
0.2
0.2
0.1
0.2
0.3
0.5
0.7
0.6
0.6
0.5
0.4
0.4
0.3
0.3
0.3
Income tax $B
0.1
−0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.1
0.2
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.1
Net income $B
0.2
−0.1
−0.1
0.1
0.1
−0.8
−1.5
0.3
0.3
0.3
0.3
0.3
0.3
0.2
0.2
0.2
0.2
0.2
EPS, diluted $
1.94
−1.19
−0.73
0.79
1.53
−9.55
−17.83
2.93
3.45
3.49
3.58
3.18
2.78
2.42
2.23
4.26
3.78
3.59
Dividend / sh $
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
·
ROE %
20.3
−12.3
−6.9
7.4
15.9
−70.9
−65.3
8.7
11.0
12.5
14.3
13.8
12.8
12.8
13.7
15.4
16.3
17.5
Shares out B
0.08
0.09
0.08
0.08
0.09
0.09
0.08
0.09
0.09
0.09
0.09
0.10
0.10
0.10
0.05
0.05
0.05
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
52 of 52
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed